Cargando…

Signalling architectures can prevent cancer evolution

Cooperation between cells in multicellular organisms is preserved by an active regulation of growth through the control of cell division. Molecular signals used by cells for tissue growth are usually present during developmental stages, angiogenesis, wound healing and other processes. In this contex...

Descripción completa

Detalles Bibliográficos
Autores principales: Oña, Leonardo, Lachmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971087/
https://www.ncbi.nlm.nih.gov/pubmed/31959809
http://dx.doi.org/10.1038/s41598-020-57494-w
_version_ 1783489646599077888
author Oña, Leonardo
Lachmann, Michael
author_facet Oña, Leonardo
Lachmann, Michael
author_sort Oña, Leonardo
collection PubMed
description Cooperation between cells in multicellular organisms is preserved by an active regulation of growth through the control of cell division. Molecular signals used by cells for tissue growth are usually present during developmental stages, angiogenesis, wound healing and other processes. In this context, the use of molecular signals triggering cell division is a puzzle, because any molecule inducing and aiding growth can be exploited by a cancer cell, disrupting cellular cooperation. A significant difference is that normal cells in a multicellular organism have evolved in competition between high-level organisms to be altruistic, being able to send signals even if it is to their detriment. Conversely, cancer cells evolve their abuse over the cancer’s lifespan by out-competing their neighbours. A successful mutation leading to cancer must evolve to be adaptive, enabling a cancer cell to send a signal that results in higher chances to be selected. Using a mathematical model of such molecular signalling mechanism, this paper argues that a signal mechanism would be effective against abuse by cancer if it affects the cell that generates the signal as well as neighbouring cells that would receive a benefit without any cost, resulting in a selective disadvantage for a cancer signalling cell. We find that such molecular signalling mechanisms normally operate in cells as exemplified by growth factors. In scenarios of global and local competition between cells, we calculate how this process affects the fixation probability of a mutant cell generating such a signal, and find that this process can play a key role in limiting the emergence of cancer.
format Online
Article
Text
id pubmed-6971087
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69710872020-01-27 Signalling architectures can prevent cancer evolution Oña, Leonardo Lachmann, Michael Sci Rep Article Cooperation between cells in multicellular organisms is preserved by an active regulation of growth through the control of cell division. Molecular signals used by cells for tissue growth are usually present during developmental stages, angiogenesis, wound healing and other processes. In this context, the use of molecular signals triggering cell division is a puzzle, because any molecule inducing and aiding growth can be exploited by a cancer cell, disrupting cellular cooperation. A significant difference is that normal cells in a multicellular organism have evolved in competition between high-level organisms to be altruistic, being able to send signals even if it is to their detriment. Conversely, cancer cells evolve their abuse over the cancer’s lifespan by out-competing their neighbours. A successful mutation leading to cancer must evolve to be adaptive, enabling a cancer cell to send a signal that results in higher chances to be selected. Using a mathematical model of such molecular signalling mechanism, this paper argues that a signal mechanism would be effective against abuse by cancer if it affects the cell that generates the signal as well as neighbouring cells that would receive a benefit without any cost, resulting in a selective disadvantage for a cancer signalling cell. We find that such molecular signalling mechanisms normally operate in cells as exemplified by growth factors. In scenarios of global and local competition between cells, we calculate how this process affects the fixation probability of a mutant cell generating such a signal, and find that this process can play a key role in limiting the emergence of cancer. Nature Publishing Group UK 2020-01-27 /pmc/articles/PMC6971087/ /pubmed/31959809 http://dx.doi.org/10.1038/s41598-020-57494-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Oña, Leonardo
Lachmann, Michael
Signalling architectures can prevent cancer evolution
title Signalling architectures can prevent cancer evolution
title_full Signalling architectures can prevent cancer evolution
title_fullStr Signalling architectures can prevent cancer evolution
title_full_unstemmed Signalling architectures can prevent cancer evolution
title_short Signalling architectures can prevent cancer evolution
title_sort signalling architectures can prevent cancer evolution
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971087/
https://www.ncbi.nlm.nih.gov/pubmed/31959809
http://dx.doi.org/10.1038/s41598-020-57494-w
work_keys_str_mv AT onaleonardo signallingarchitecturescanpreventcancerevolution
AT lachmannmichael signallingarchitecturescanpreventcancerevolution